Saturn V Capital Management »

Lenz Therapeutics shares owned by Saturn V Capital Management

Quarter-by-quarter ownership of Lenz Therapeutics (LENZ) shares owned by Saturn V Capital Management from 13F filings

Historical chart of Saturn V Capital Management investment in Lenz Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lenz Therapeutics held by Saturn V Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lenz Therapeutics by Saturn V Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $17M 368k 46.58
2025-06-30 $10M 342k 29.31

More positions owned by Saturn V Capital Management

Abivax Sa Sponsored Ads (ABVX)
Amylyx Pharmaceuticals (AMLX)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Dyne Therapeutics (DYN)
Cogent Biosciences (COGT)
Vaxcyte (PCVX)
Celcuity (CELC)
Cg Oncology (CGON)
Disc Medicine (IRON)
Pharvaris N V (PHVS)
Xenon Pharmaceuticals (XENE)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Merus N V (MRUS)
Lenz Therapeutics (LENZ)
Ocular Therapeutix (OCUL)

View all positions for Saturn V Capital Management

Top funds holding Lenz Therapeutics

RA Capital Management
Falcon Edge Capital
Versant Venture Management
UBS Group
BlackRock
Vanguard Group
Paradigm Biocapital Advisors
72 Investment Holdings
Tang Capital Management
Rtw Investments
First Light Asset Management
Adage Capital Partners GP
Franklin Resources
Standard Life Aberdeen
Geode Capital Management

View all funds holding Lenz Therapeutics